Evidence map›Paper›PMID 36551750›Full record

ReviewCancers2022

A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases.

Julian Mangesius, Stephanie Mangesius, Matthias Demetz, Christian Uprimny, Gianpaolo Di Santo, Malik Galijasevic, Danijela Minasch, Elke R Gizewski, Ute Ganswindt, Irene Virgolini and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Julian MangesiusDepartment of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-0855-1870
Stephanie MangesiusDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-5790-2724
Matthias DemetzDepartment of Neurosurgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Christian UprimnyDepartment of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Gianpaolo Di SantoDepartment of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Malik GalijasevicDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6577-0784
Danijela MinaschDepartment of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Elke R GizewskiDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Ute GanswindtDepartment of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Irene VirgoliniDepartment of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-7097-6170
Claudius ThoméDepartment of Neurosurgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Christian F FreyschlagDepartment of Neurosurgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-8228-8217
Johannes KerschbaumerDepartment of Neurosurgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Innsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation necrosis represents a potentially devastating complication after radiation therapy in brain tumors. The establishment of the diagnosis and especially the differentiation from progression and pseudoprogression with its therapeutic implications requires interdisciplinary consent and monitoring. Herein, we want to provide an overview of the diagnostic modalities, therapeutic possibilities and an outlook on future developments to tackle this challenging topic. The aim of this report is to provide an overview of the current morphological, functional, metabolic and evolving imaging tools described in the literature in order to (I) identify the best criteria to distinguish radionecrosis from tumor recurrence after the radio-oncological treatment of malignant gliomas and cerebral metastases, (II) analyze the therapeutic possibilities and (III) give an outlook on future developments to tackle this challenging topic. Additionally, we provide the experience of a tertiary tumor center with this important issue in neuro-oncology and provide an institutional pathway dealing with this problem.

Indexed as

brain metastasesgliomaMRImulti-disciplinaryradionecrosisradiotherapytumor recurrence

Identifiers

PMID36551750
PMCPMC9777318
OpenAlexW4312140364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.